Evidence map›Paper›PMID 42619981›Full record

ArticleResearch square2026

Mouse genetic mosaic model for basal-like breast cancer reveals disruption of basal-myoepithelial architecture at premalignancy.

Alexys T Riddick, Xian Zhou, Hui Zong

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alexys T RiddickUniversity of Virginia.
Xian ZhouUniversity of Virginia.
Hui ZongUniversity of Virginia.

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Dina Gould Halme · 1987 to 2026
$72.1M
Cancer Research Training Program: From Molecular Mechanisms to Therapeutic StrategiesT32CA009109 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Andrew Carl Dudley, Melanie R Rutkowski · 1985 to 2026
$13.9M
A premalignant chronology of cell-state variability in basal-like breast cancerR01CA256199 · NCI · UNIVERSITY OF VIRGINIA · PI Andrew Carl Dudley, Kevin A Janes · 2022 to 2026
$3.4M
Elucidate the role of B/T cell-enriched immune aggregates in immune surveillance against TNBCR21CA297427 · NCI · UNIVERSITY OF VIRGINIA · PI Hui Zong · 2025 to 2026
$415k
NCI NIH HHS P30 CA044579NCI NIH HHS R01 CA256199NCI NIH HHS R21 CA297427NCI NIH HHS T32 CA009109
6 · The paper itself

Abstract

In early cancer evolution, mutant cells must escape tissue-architectural constraints before progressing to malignancy. In the case of invasive breast cancers, loss of integrity of the wildtype basal-myoepithelial layer that wraps around premalignant luminal cells precedes the formation of an invasive tumor mass. The spatiotemporal details of these early events have remained elusive. Here, we used the Mosaic Analysis with Double Markers (MADM) mouse model of basal-like breast cancer to generate rare, GFP-labeled, premalignant luminal cells within an otherwise colorless, normal mouse, and pinpointed hyperalveolarization from the ducts as a key phase of progression, several months before malignant transformation. Using a whole-mount tissue clearing-staining-imaging workflow to examine the colorless basal-myoepithelial cell layer that surrounds GFP-labeled premalignant luminal cells, we observed a gradual disruption of the basal-myoepithelial layer during the hyperalveolarization phase. Increased cell size, altered cell morphology, and elevated proliferation of mutant cells occurred independently of basal disruption. In contrast, expression of the basal marker Keratin 14 in premalignant luminal cells, a feature that contributes to the "basal-like" nomenclature of this cancer, was strongly associated with basal disruption, suggesting that basal cell-mediated containment may suppress a critical transition in premalignant cell state. This work identifies disruption of the basal cell layer as an early hallmark of premalignant progression, supporting a chronology in which architectural remodeling of the mammary epithelium precedes malignant progression.

Indexed as

basal-like breast cancerbasal-myoepithelial architecturemouse genetic mosaic modelpremalignancywhole-mount imaging

Identifiers

PMID42619981
PMCPMC13484406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.